Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Fumiharu, Yagasaki"'
Autor:
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Kazuhiro Nishii, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, Atsuo Maruta, Hiroto Narimatsu, Yasushi Miyazaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno
Publikováno v:
Haematologica, Vol 93, Iss 2 (2008)
To identify factors associated with relapse-free survival (RFS), 80 patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, enrolled in a phase II study of imatinib-combined chemotherapy, were analyzed. The median
Externí odkaz:
https://doaj.org/article/5e4b4da313874836a8be830d424b4481
Autor:
Shin Fujisawa, Norio Asou, Kazunori Ohnishi, Hitoshi Kiyoi, Atsushi Fujieda, Hisashi Sakamaki, Sumihisa Honda, Shigeki Ohtake, Noriko Usui, Yasushi Miyazaki, Yukihiko Kimura, Shuichi Miyawaki, Takahisa Yamane, Ryuzo Ohno, Tadashi Nagai, Toru Sakura, Chiaki Nakaseko, Masatomo Takahashi, Katsuji Shinagawa, Koichi Miyamura, Hiroshi Handa, Masafumi Taniwaki, Fumiharu Yagasaki, Tomoki Naoe
Publikováno v:
Blood. 117:2366-2372
We conducted a prospective randomized study to assess the optimal postremission therapy for adult acute myeloid leukemia in patients younger than 65 years in the first complete remission. A total of 781 patients in complete remission were randomly as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c78ef0badf8065bd862d7f0af3cb1e
https://doi.org/10.1182/blood-2010-07-295279
https://doi.org/10.1182/blood-2010-07-295279
Autor:
Yuji Kishimoto, Masako Iwanaga, Shigeo Horiike, Masayuki Kato, Motohiro Tsuzuki, Kazunori Ohnishi, Hirokazu Okumura, Yasushi Miyazaki, Shuichi Miyawaki, Yasunori Ueda, Yasuhiro Maeda, Noriko Usui, Jin Takeuchi, Fumiharu Yagasaki, Tohru Sakura, R Ohno, Itsuro Jinnai, Taiichi Kyo, Kosuke Tsuboi, Tomoki Naoe
Publikováno v:
International Journal of Hematology. 92:490-502
We designed a treatment protocol for newly diagnosed adult acute lymphoblastic leukemia (ALL) in the pre-imatinib era, employing intensified consolidation therapy with a total of 330 mg/m² doxorubicin and adopting slightly modified induction and mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40288d834e12ec216c24d2f99ad1342
https://doi.org/10.1007/s12185-010-0672-z
https://doi.org/10.1007/s12185-010-0672-z
Autor:
Shin Matsuda, Masatomo Takahashi, Yuji Kishimoto, Yasushi Miyazaki, Ryuzo Ohno, Kinuko Mitani, Nobuhiko Emi, Norio Asou, Shigeki Ohtake, Fumiharu Yagasaki, Sumihisa Honda, Shuichi Miyawaki, Hisashi Sakamaki, Yoshiaki Ogawa
Publikováno v:
International Journal of Hematology. 91:284-292
We prospectively compared allogeneic hematopoietic stem cell transplantation (allo-HSCT) with chemotherapy as a post-remission therapy in a multicenter trial (JALSG AML97) of adult patients with intermediate or poor risk acute myeloid leukemia (AML).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b019e474bf5a4123b80c8911768f6b28
https://doi.org/10.1007/s12185-009-0483-2
https://doi.org/10.1007/s12185-009-0483-2
Autor:
Atsushi Kato, Hiroki Yamaguchi, Koiti Inokuchi, Kazuma Ohyashiki, Satoshi Takahashi, Hirokazu Okumura, Arinobu Tojo, Seiji Gomi, Kazuo Dan, Naoto Takahashi, Fumiharu Yagasaki, Hisashi Sakamaki, Kazuo Oshimi, Ayako Arai, Noriko Usui, Masami Bessho, Shinji Nakao, Hiroyuki Hamaguchi, Kenichi Sawada, Ken Ohmine, Keisuke Miyazawa, Keiya Ozawa, Takeshi Kobayashi, Yoshiro Murai, Hayato Tamai, Osamu Miura, Shigeo Toyota, Hideki Akiyama
Publikováno v:
International Journal of Hematology. 87:195-202
To clarify the clinical features of adult patients with acute leukemia (AL) with 11q23 abnormalities, we performed a retrospective analysis of data from 58 adult Japanese patients: 51 with acute myeloid leukemia (AML), and 7 with acute lymphoblastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a4af55a9a5150eb6f610d4cc438258
https://doi.org/10.1007/s12185-008-0034-2
https://doi.org/10.1007/s12185-008-0034-2
Autor:
Yukihiko Kimura, Tomoki Naoe, Akihiro Takeshita, Masako Iwanaga, Norio Asou, Katsuji Shinagawa, Tohru Kobayashi, Masaya Okada, Shigeki Ohtake, Hitoshi Kiyoi, Masatomo Takahashi, Fumiharu Yagasaki, Motohiro Tsuzuki, Mitsuhiro Matsuda, Miki Nishimura, Ryuzo Ohno, Yasukazu Kawai, Kentaro Horikawa, Yuji Kishimoto
Publikováno v:
Blood. 110:59-66
To examine the efficacy of intensified maintenance chemotherapy, we conducted a prospective multicenter trial in adult patients with newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Of the 302 regist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c86f6f99bebad6551c0667809db5823
https://doi.org/10.1182/blood-2006-08-043992
https://doi.org/10.1182/blood-2006-08-043992
Autor:
Maho, Ishikawa, Fumiharu, Yagasaki, Daisuke, Okamura, Tomoya, Maeda, Yuichi, Sugahara, Itsuro, Jinnai, Masami, Bessho
Publikováno v:
International Journal of Hematology. 86:238-245
We identified a novel gene fusion of ANKRD28 (ankyrin repeat domain 28) on 3p25 to NUP98 on 11p15 in a patient with adult myelodysplastic syndrome/acute myelogenous leukemia. A partially cryptic 3-way translocation, t(3;5;11)(p25;q35;p15), that had i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2888654b8a28b1d2fd13ceebeee15b9d
https://doi.org/10.1007/bf03006927
https://doi.org/10.1007/bf03006927
Autor:
Fumiharu Yagasaki
Publikováno v:
Nihon Naika Gakkai Zasshi. 96:1411-1419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df75fabe91a14f8397ca09e818728437
https://doi.org/10.2169/naika.96.1411
https://doi.org/10.2169/naika.96.1411
Autor:
Akira Miyata, Masaaki Higashihara, Kazuo Oshimi, Mayumi Mori, Fumiharu Yagasaki, Masatsugu Ohta, Kazutaka Sunami, Hideo Kimura
Publikováno v:
Leukemia & Lymphoma. 47:2062-2069
The feasibility and effects of combination chemotherapy for very elderly patients with acute myeloid leukemia was examined in 65 patients (including previous myelodysplastic syndrome) aged 76 years or morewith a performance status of 0 - 3. Induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc76a68db238386e40151e9ccd5ce3f3
https://doi.org/10.1080/10428190600733317
https://doi.org/10.1080/10428190600733317
Autor:
Yoshiaki Ogawa, Norio Asou, Sumihisa Honda, Fumiharu Yagasaki, Yuji Kishimoto, Masatomo Takahashi, Shin Matsuda, Nobuhiko Emi, Hisashi Sakamaki, Ryuzo Ohno, Yasushi Miyazaki, Shuichi Miyawaki, Kinuko Mitani, Shigeki Ohtake, Takafumi Matsushima
Publikováno v:
Cancer. 104:2726-2734
BACKGROUND A major concern in the treatment of patients with acute myeloid leukemia (AML) is how to prevent disease recurrences. Although intensive consolidation therapy has proven useful, the effectiveness of maintenance therapy remains controversia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2c32f0b03b22af08c4c2019171ed88
https://doi.org/10.1002/cncr.21493
https://doi.org/10.1002/cncr.21493